1 Introduction
The role of peroxisomes in brain development has been evident for many decades following the discovery that defects in peroxisome biogenesis lead to Zellweger Spectrum Diseases (ZSD) which presents neurodevelopmental failure (Faust et al., 2005; Berger et al., 2016). Peroxisomes perform essential biochemical functions, including the synthesis of omega-3 polyunsaturated fatty acids (PUFAs), which are critical for brain and neuronal health, and the catabolism of very long-chain fatty acids (VLCFAs) and reactive oxygen and nitrogen species. These processes are particularly important in the brain, where metabolic imbalances or toxic accumulations can disrupt development and function (Carmichael, 2025). Growing evidence demonstrates that peroxisomal metabolites and signaling functions are required in various brain cell types, including neurons, microglia, and oligodendrocytes. This suggests that peroxisomes support brain health through both cell-type-specific and broader metabolic mechanisms. Moreover, extra brain peroxisomal activities, for instance in the liver, are also critical for brain development and function, and their impairment can contribute to diseases such as ZSD or intellectual disabilities (Janssen et al., 2003). A recent work also suggests that peroxisomes may regulate the microbiota-gut-brain axis. Indeed, a supplementation with Lactobacillus acidophilus improved outcomes in a mouse model of cerebral ischemia by increasing intestinal absorption of linoleic acid that reaches the brain and activates peroxisomes in microglia, promoting their shift to an anti-inflammatory state (Huang et al., 2025). This work also opens the possibility that peroxisomes in the intestinal epithelium may contribute to the production of metabolites that control brain functions or inflammatory status. This concept may extend to crosstalk between the brain and other peripheral tissues, such as adipose tissue or muscle.
Moreover, research in neurodegenerative diseases has also found that peroxisome metabolites are required to maintain a healthy brain over aging, and alterations in the brain or in the circulation of peroxisomal lipids have been linked to the onset of neurodegenerative conditions such as Alzheimer's and Parkinson's disease (Fabelo et al., 2011; Lizard et al., 2012; Roczkowsky et al., 2025). This is in line with the recent demonstration that impaired peroxisomal β-oxidation contributes to microglial dysfunction, linking peroxisomes to the progression of Alzheimer's disease (Gao et al., 2025). Yet, whether the mechanisms of health/disease of the brain during aging are neuronal-specific, brain-specific, or of extra-brain origins remains understudied. Here, we comment on current knowledge linking peroxisomes to brain health, suggesting new directions and technologies to expand this crucial and interesting area of the role of peroxisomes in brain physiology.
2 Cell-specificity of peroxisomes and peroxisomal metabolism in the brain
Peroxisomes exhibit remarkable abundance and functional diversity across the various cell types of the nervous system, encompassing neurons, astrocytes, oligodendrocytes, and microglia (Deb et al., 2021). Deciphering the precise functional roles of peroxisomes within individual cell types remains a significant scientific challenge. While peroxisomes are known to play an essential role in lipid metabolism, redox balance, and cell signaling, their specific activities and the consequences of their dysfunction can vary considerably depending on the tissue and cellular context. To address this complexity, tissue-specific and cell-type-specific knockout models have become invaluable tools (Baes et al., 2002; Kassmann et al., 2007; Krysko et al., 2007; Baes and Van Veldhoven, 2012; Verheijden et al., 2014; Di Cara et al., 2017; Beckers et al., 2018, 2019; Raas et al., 2019a,b, 2023; Tawbeh et al., 2023, 2025). While these approaches have provided critical insights into the role of peroxisomes in neurons, astrocytes, oligodendrocytes, and microglia, many questions remain unanswered.
The expression pattern of peroxisome proliferator-activated receptors (PPARs), nuclear receptors involved in peroxisome proliferation and controlling the expression of many peroxisomal genes, likely reflects the importance of peroxisomes and their ability to adapt their number and the nature of their protein content to various stimuli (Kainu et al., 1994; Braissant et al., 1996; Woods et al., 2003). Notably, PPAR-dependent regulation of peroxisomes is highly species-specific, with marked differences between rodents and humans, which has important implications for translating findings from animal models to human brain physiology (Mast et al., 2025). In the brain and despite their ubiquity, the cell-type-specific functions of peroxisomes and their dynamic adaptations depending on aging, nutritional environment, or pathological stimuli remain elusive. Many studies based on in situ hybridization and immunohistochemistry have significantly contributed to highlight the key roles of peroxisomes in the brain; however, these studies were usually limited to a single specific target or a specific pathological condition and did not provide a dynamic view or an understanding of the differences existing between peroxisomes depending on the cells, organ areas, and contexts. Among these, there are studies focusing on the expression of ABCD1-3 proteins, which transport various lipidic substrates through the peroxisomal membrane (Pollard et al., 1995; Troffer-Charlier et al., 1998; Fanelli et al., 2013), NOS2, the inducible nitric oxide synthase partially localized in the peroxisome (Gilg et al., 2000), PEX14, a translocon protein and Catalase, the enzyme in charge of hydrogen peroxide catabolism (Semikasev et al., 2023) in distinct areas. The upcoming implementation of new cutting-edge single-cell RNA sequencing and spatial transcriptomics technologies, such as RNAscope, holds significant promise for precisely elucidating the cellular distribution of peroxisomal gene expression (Piwecka et al., 2023; Secci et al., 2023). Spatial mass spectrometry [matrix-assisted laser desorption/ionization (MALDI) or desorption electrospray ionization (DESI)] is another powerful technique to visualize the spatial distribution and dynamics of peroxisomal proteins in cellular contexts, thereby helping in elucidating the cellular and physiological role of peroxisomes in the nervous tissues (Gessel et al., 2014), especially when combined with other high-throughput special analyses such as spatial lipidomics (Opielka et al., 2025). The combination of these approaches would also inform us about the relationships of peroxisomes with other cellular compartments, helping to define the poorly understood metabolic fluxes in which they participate. Peroxisomes physically interact with ER, mitochondria, lysosomes, and lipid droplets, and are now emerging as signaling hub organelles coordinating lipid metabolism, redox homeostasis, thermogenesis and inflammatory responses (Park et al., 2019; Di Cara et al., 2023; Kumar et al., 2024). Understanding the dynamics of lipid turnover for metabolic reprogramming of organelles and the synthesis or the degradation of signaling lipids such as eicosanoids will be critical to anticipate and describe neuronal and glial functions in health and disease status.
3 Peroxisomes at the crossroads of brain neuroinflammation: linking microglia and disease
Regarding inflammatory response in nervous tissues, that can be both beneficial and detrimental depending on the context and the timing of the response, the role of peroxisomes has often been underrated. Several studies have highlighted the importance of peroxisomes in producing and releasing pro-inflammatory cytokines such as TNF or IL1B (Nath et al., 2022; Roczkowsky et al., 2025). However, a comprehensive understanding of their role throughout the different phases of the inflammatory response, from initiation to resolution, remains lacking. This is also true for the dynamics of inflammatory mediators. Peroxisomal lipid metabolism also contributes to the production of lipid mediators such as PUFAs, eicosanoids, and docosanoids (Savary et al., 2012). However, the cellular cascades regulating the production of these lipids in peroxisomes, and the mechanisms governing their dynamics remain undefined.
Microglia, through their plasticity, their diversity of function, and their ability to migrate and communicate with other brain cells, are obviously central in the brain homeostasis (Muzio et al., 2021). Regarding the pathogenesis of peroxisomal disorders, especially X-linked adrenoleuokodystrophy, reconciliating biochemical observations such as VLCFA accumulation, cell toxicity, inflammation, demyelination, and neurodegeneration, and providing a comprehensive sequence of events explaining the disease evolution in patients, constitutes a true challenge. Recent findings have highlighted the key role of peroxisomes in microglia and their involvement in various cellular processes such as phagocytosis of myelin and cell signaling (Raas et al., 2023; Tawbeh et al., 2023; Barnes-Velez et al., 2025; Tawbeh et al., 2025).
These insights have generated new hypotheses regarding our understanding of the pathogenesis of peroxisomal diseases, which place microglia and their communication with neurons as a key alteration in disease onset (Bergner et al., 2019; Yska et al., 2024). Of course, it does not exclude a role for other glial cell types or extracellular vesicles (EVs). EVs could participate in long-range intercellular communication by transporting reactive oxygen species, lipids or other signaling molecules generated in response to peroxisomal alterations, and possibly entire organelles (Ghadami and Dellinger, 2023). This could facilitate the propagation of dysfunctional signals, potentially exacerbating disease progression. Conversely, EVs, and not only the supposed functional replacement of microglia by healthy macrophages, could be a key component explaining how hematopoietic stem cell gene therapy contributes to halting disease progression (Mallack et al., 2019), a hypothesis that warrants further study.
4 Discussion
Recent research has brought to light the complexity in understanding the requirement for peroxisomes and their metabolism for brain health. It is obvious that regionality, cell-specificity, and local vs. distal signaling need to be analyzed and considered to define the peroxisomal role in brain health and, most importantly, to identify the alteration of peroxisomal signaling that impacts brain development and functions in various pathological conditions. Our commentary hopes to direct research in the field toward more integrated analyses and exploring multiple model organisms to advance the field and address outstanding questions such as:
-
What are the cell-specific peroxisomal contributions in the developing and adult brain?
-
How do peroxisomes outside the brain impact developmental neurogenesis and brain health?
-
Are peroxisomes fundamental players in the microbiota-gut-brain axis?
Statements
Author contributions
FD: Writing – original draft, Writing – review & editing. SS: Writing – original draft, Writing – review & editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. The study was supported by CIHR project grant PJT-204109 to FD.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Baes M. Dewerchin M. Janssen A. Collen D. Carmeliet P. (2002). Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes. Genesis32, 177–178. doi: 10.1002/gene.10047
2
Baes M. Van Veldhoven P. P. (2012). Mouse models for peroxisome biogenesis defects and beta-oxidation enzyme deficiencies. Biochim. Biophys. Acta1822, 1489–1500. doi: 10.1016/j.bbadis.2012.03.003
3
Barnes-Velez J. A. Zhang X. Pena Seneriz Y. L. Scott K. A. Guan Y. Hu J. (2025). Peroxisomal integrity in demyelination-associated microglia enables cellular debris clearance and myelin renewal in mice. J. Clin. Invest. 136:e179985. doi: 10.1172/JCI179985
4
Beckers L. Geric I. Stroobants S. Beel S. Van Damme P. D'Hooge R. et al . (2019). Microglia lacking a peroxisomal beta-oxidation enzyme chronically alter their inflammatory profile without evoking neuronal and behavioral deficits. J. Neuroinflamm.16:61. doi: 10.1186/s12974-019-1442-3
5
Beckers L. Stroobants S. D'Hooge R. Baes M. (2018). Neuronal dysfunction and behavioral abnormalities are evoked by neural cells and aggravated by inflammatory microglia in peroxisomal β-oxidation deficiency. Front. Cell. Neurosci.12:136. doi: 10.3389/fncel.2018.00136
6
Berger J. Dorninger F. Forss-Petter S. Kunze M. (2016). Peroxisomes in brain development and function. Biochim. Biophys. Acta1863, 934–955. doi: 10.1016/j.bbamcr.2015.12.005
7
Bergner C. G. van der Meer F. Winkler A. Wrzos C. Turkmen M. Valizada E. et al . (2019). Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia67, 1196–1209. doi: 10.1002/glia.23598
8
Braissant O. Foufelle F. Scotto C. Dauca M. Wahli W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology137, 354–366. doi: 10.1210/endo.137.1.8536636
9
Carmichael R. E. (2025). Peroxisome dynamics and inter-organelle interactions in neuronal health and disease. Front Mol Neurosci18, 1603632. doi: 10.3389/fnmol.2025.1603632
10
Deb R. Joshi N. Nagotu S. (2021). Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases. Neurotox. Res.39, 986–1006. doi: 10.1007/s12640-020-00323-9
11
Di Cara F. Savary S. Kovacs W. J. Kim P. Rachubinski R. A. (2023). The peroxisome: an up-and-coming organelle in immunometabolism. Trends Cell Biol.33, 70–86. doi: 10.1016/j.tcb.2022.06.001
12
Di Cara F. Sheshachalam A. Braverman N. E. Rachubinski R. A. Simmonds A. J. (2017). Peroxisome-mediated metabolism is required for immune response to microbial infection. Immunity47, 93–106.e107. doi: 10.1016/j.immuni.2017.06.016
13
Fabelo N. Martin V. Santpere G. Marin R. Torrent L. Ferrer I. et al . (2011). Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol. Med.17, 1107–1118. doi: 10.2119/molmed.2011.00119
14
Fanelli F. Sepe S. D'Amelio M. Bernardi C. Cristiano L. Cimini A. et al . (2013). Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol. Neurodegener.8:8. doi: 10.1186/1750-1326-8-8
15
Faust P. L. Banka D. Siriratsivawong R. Ng V. G. Wikander T. M. (2005). Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J. Inherit. Metab. Dis.28, 369–383. doi: 10.1007/s10545-005-7059-y
16
Gao M. Bai J. Lou F. Sun Y. Wang Z. Cai X. et al . (2025). Loss of MFE-2 impairs microglial lipid homeostasis and drives neuroinflammation in Alzheimer's pathogenesis. Nat. Aging5, 2279–2296. doi: 10.1038/s43587-025-00976-1
17
Gessel M. M. Norris J. L. Caprioli R. M. (2014). MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J. Proteomics107, 71–82. doi: 10.1016/j.jprot.2014.03.021
18
Ghadami S. Dellinger K. (2023). The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery. Front. Mol. Biosci.10:1198044. doi: 10.3389/fmolb.2023.1198044
19
Gilg A. G. Singh A. K. Singh I. (2000). Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy. J. Neuropathol. Exp. Neurol.59, 1063–1069. doi: 10.1093/jnen/59.12.1063
20
Huang Y. Zhang X. Yu C. Liu Y. Kang H. Liu Y. et al . (2025). Lactobacillus acidophilus promotes cognitive function recovery via regulating microglial peroxisomal function in cerebral ischemia. Cell Host Microbe 33 1484–1501 e1412. doi: 10.1016/j.chom.2025.07.018
21
Janssen A. Gressens P. Grabenbauer M. Baumgart E. Schad A. Vanhorebeek I. et al . (2003). Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J. Neurosci.23, 9732–9741. doi: 10.1523/JNEUROSCI.23-30-09732.2003
22
Kainu T. Wikstrom A. C. Gustafsson J. A. Pelto Huikko M. (1994). Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport5, 2481–2485. doi: 10.1097/00001756-199412000-00019
23
Kassmann C. M. Lappe-Siefke C. Baes M. Brugger B. Mildner A. Werner H. B. et al . (2007). Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet.39, 969–976. doi: 10.1038/ng2070
24
Krysko O. Hulshagen L. Janssen A. Schutz G. Klein R. De Bruycker M. et al . (2007). Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver. J. Neurosci. Res.85, 58–72. doi: 10.1002/jnr.21097
25
Kumar R. Islinger M. Worthy H. Carmichael R. Schrader M. (2024). The peroxisome: an update on mysteries 3.0. Histochem. Cell Biol.161, 99–132. doi: 10.1007/s00418-023-02259-5
26
Lizard G. Rouaud O. Demarquoy J. Cherkaoui-Malki M. Iuliano L. (2012). Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. J. Alzheimers Dis.29, 241–254. doi: 10.3233/JAD-2011-111163
27
Mallack E. J. Turk B. Yan H. Eichler F. S. (2019). The landscape of hematopoietic stem cell transplant and gene therapy for X-linked adrenoleukodystrophy. Curr. Treat. Options Neurol.21:61. doi: 10.1007/s11940-019-0605-y
28
Mast F. D. Rachubinski R. A. Aitchison J. D. (2025). Reevaluating the roles of PPARs and nuclear receptors in human peroxisome biology. J. Cell Biol.224:e202506162. doi: 10.1083/jcb.202506162
29
Muzio L. Viotti A. Martino G. (2021). Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front. Neurosci.15:742065. doi: 10.3389/fnins.2021.742065
30
Nath A. S. Parsons B. D. Makdissi S. Chilvers R. L. Mu Y. Weaver C. M. et al . (2022). Modulation of the cell membrane lipid milieu by peroxisomal beta-oxidation induces Rho1 signaling to trigger inflammatory responses. Cell Rep.38:110433. doi: 10.1016/j.celrep.2022.110433
31
Opielka M. Urbanowicz K. Konieczna-Wolska K. Müller E. Krajewski O. Feucherolles M. et al . (2025). Spatial lipidomics reveals demyelination and remyelination dynamics in the mouse brain. J. Lipid Res.66:100912. doi: 10.1016/j.jlr.2025.100912
32
Park H. He A. Tan M. Johnson J. M. Dean J. M. Pietka T. A. et al . (2019). Peroxisome-derived lipids regulate adipose thermogenesis by mediating cold-induced mitochondrial fission. J. Clin. Invest.129, 694–711. doi: 10.1172/JCI120606
33
Piwecka M. Rajewsky N. Rybak-Wolf A. (2023). Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat. Rev. Neurol.19, 346–362. doi: 10.1038/s41582-023-00809-y
34
Pollard H. Moreau J. Aubourg P. (1995). Localization of mRNAs for adrenoleukodystrophy and the 70 kDa peroxisomal (PMP70) proteins in the rat brain during post-natal development. J. Neurosci. Res.42, 433–437. doi: 10.1002/jnr.490420318
35
Raas Q. Gondcaille C. Hamon Y. Leoni V. Caccia C. Ménétrier F. et al . (2019a). CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy. Biochim. Biophys. Acta Mol. Cell Biol. Lipids1864, 704–714. doi: 10.1016/j.bbalip.2019.02.006
36
Raas Q. Saih F. E. Gondcaille C. Trompier D. Hamon Y. Leoni V. et al . (2019b). A microglial cell model for acyl-CoA oxidase 1 deficiency. Biochim. Biophys. Acta Mol. Cell Biol. Lipids1864, 567–576. doi: 10.1016/j.bbalip.2018.10.005
37
Raas Q. Tawbeh A. Tahri-Joutey M. Gondcaille C. Keime C. Kaiser R. et al . (2023). Peroxisomal defects in microglial cells induce a disease-associated microglial signature. Front. Mol. Neurosci.16:1170313. doi: 10.3389/fnmol.2023.1170313
38
Roczkowsky A. Rachubinski R. A. Hobman T. C. Power C. (2025). Peroxisomes as emerging clinical targets in neuroinflammatory diseases. Front. Mol. Neurosci.18:1642590. doi: 10.3389/fnmol.2025.1642590
39
Savary S. Trompier D. Andreoletti P. Le Borgne F. Demarquoy J. Lizard G. (2012). Fatty acids - induced lipotoxicity and inflammation. Curr. Drug Metab.13, 1358–1370. doi: 10.2174/138920012803762729
40
Secci M. E. Reed T. Quinlan V. Gilpin N. W. Avegno E. M. (2023). Quantitative analysis of gene expression in rnascope-processed brain tissue. Bio-Protoc.13:e4580. doi: 10.21769/BioProtoc.4580
41
Semikasev E. Ahlemeyer B. Acker T. Schänzer A. Baumgart-Vogt E. (2023). Rise and fall of peroxisomes during Alzheimer's disease: a pilot study in human brains. Acta Neuropathol. Commun.11:80. doi: 10.1186/s40478-023-01567-0
42
Tawbeh A. Gondcaille C. Saih F.-E. Raas Q. Loichot D. Hamon Y. et al . (2025). Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes. Front. Mol. Neurosci.18:1542938. doi: 10.3389/fnmol.2025.1542938
43
Tawbeh A. Raas Q. Tahri-Joutey M. Keime C. Kaiser R. Trompier D. et al . (2023). Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation. Front. Mol. Neurosci.16:1299314. doi: 10.3389/fnmol.2023.1299314
44
Troffer-Charlier N. Doerflinger N. Metzger E. Fouquet F. Mandel J. L. Aubourg P. (1998). Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. Eur. J. Cell. Biol.75, 254–264. doi: 10.1016/S0171-9335(98)80121-0
45
Verheijden S. Beckers L. De Munter S. Van Veldhoven P. P. Baes M. (2014). Central nervous system pathology in MFP2 deficiency: insights from general and conditional knockout mouse models. Biochimie98, 119–126. doi: 10.1016/j.biochi.2013.08.009
46
Woods J. W. Tanen M. Figueroa D. J. Biswas C. Zycband E. Moller D. E. et al . (2003). Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Brain Res.975, 10–21. doi: 10.1016/S0006-8993(03)02515-0
47
Yska H. A. F. Engelen M. Bugiani M. (2024). The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology. Orphanet J. Rare Dis.19:138. doi: 10.1186/s13023-024-03105-0
Summary
Keywords
lipid metabolism, microglia, nervous system, neuroinflammation, peroxisome signalling
Citation
Di Cara F and Savary S (2026) Peroxisomes and the nervous system: progress and challenges in neuroinflammation and cell-specific functions. Front. Mol. Neurosci. 19:1745086. doi: 10.3389/fnmol.2026.1745086
Received
12 November 2025
Revised
23 January 2026
Accepted
26 January 2026
Published
11 February 2026
Volume
19 - 2026
Edited by
Nicolau Beckmann, Novartis Institutes for BioMedical Research, Switzerland
Reviewed by
Ruth E. Carmichael, University of Exeter, United Kingdom
Gilles Sansig, Novartis, Switzerland
Updates
Copyright
© 2026 Di Cara and Savary.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Stéphane Savary, stsavary@u-bourgogne.fr
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.